Valuation: Giant Biogene Holding Co., Ltd.

Capitalization 49.62B 54.25B 6.91B 6B 5.65B 5.13B 9.49B 599B 10.7B 66.87B 25.59B 274B 25.93B 25.38B 1,008B P/E ratio 2025 *
19x
P/E ratio 2026 * 15.3x
Enterprise value 43.63B 47.71B 6.08B 5.27B 4.97B 4.51B 8.35B 526B 9.4B 58.8B 22.5B 241B 22.8B 22.32B 886B EV / Sales 2025 *
6.05x
EV / Sales 2026 * 4.59x
Free-Float
42.68%
Yield 2025 *
2.46%
Yield 2026 * 3.03%
More valuation ratios * Estimated data
Dynamic Chart
1 day+1.99%
1 week-13.79%
Current month-27.82%
1 month-37.31%
3 months-26.36%
6 months-0.19%
Current year+2.71%
More quotes
1 week 49.6
Extreme 49.6
59.5
1 month 49.6
Extreme 49.6
81.8
Current year 45.2
Extreme 45.2
87.1
1 year 35
Extreme 35
87.1
3 years 24.3
Extreme 24.3
87.1
5 years 24.3
Extreme 24.3
87.1
10 years 24.3
Extreme 24.3
87.1
More quotes
Manager TitleAgeSince
Chief Executive Officer 58 2022-04-20
Director of Finance/CFO 38 2022-04-20
Corporate Secretary 29 2018-09-30
Director TitleAgeSince
Chairman 58 2022-04-20
Director/Board Member 54 2021-11-29
Director/Board Member 66 2022-10-05
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+1.99%-13.79%+11.66% - 6.91B
+0.67%-0.75%-5.46%+16.65% 373B
-0.31%-1.55%+2.91%+26.63% 153B
-0.46%-2.75%-9.76%+14.81% 71.14B
+0.52%-0.55%-5.53%+4.59% 62.56B
+0.14%-0.28%+15.43% - 41.07B
+0.42%-7.75%-24.47%+13.20% 27.09B
+0.63%+11.71%-33.96%-69.53% 27.05B
-0.53%-1.29%-5.96%+2.76% 18.58B
-0.39%+0.05%-12.34%+56.09% 14.05B
Average +0.27%-1.92%-6.75%+8.15% 79.45B
Weighted average by Cap. +0.30%-1.02%-4.76%+14.66%
See all sector performances

Financials

2025 *2026 *
Net sales 7.21B 7.89B 1B 872M 821M 746M 1.38B 87.02B 1.55B 9.72B 3.72B 39.87B 3.77B 3.69B 147B 9.16B 10.02B 1.28B 1.11B 1.04B 947M 1.75B 111B 1.97B 12.35B 4.73B 50.64B 4.79B 4.69B 186B
Net income 2.56B 2.8B 357M 310M 292M 265M 490M 30.91B 552M 3.45B 1.32B 14.16B 1.34B 1.31B 52.06B 3.19B 3.49B 445M 386M 363M 330M 611M 38.51B 688M 4.3B 1.65B 17.64B 1.67B 1.63B 64.86B
Net Debt -5.99B -6.55B -834M -724M -682M -619M -1.15B -72.26B -1.29B -8.07B -3.09B -33.1B -3.13B -3.06B -122B -7.59B -8.3B -1.06B -917M -863M -785M -1.45B -91.52B -1.64B -10.22B -3.91B -41.93B -3.97B -3.88B -154B
More financial data * Estimated data
Logo Giant Biogene Holding Co., Ltd.
Giant Biogene Holding Co Ltd is a China-based investment holding company. The Company is principally engaged the research, development, manufacture and sale of bioactive material-based beauty and health products through its subsidiaries. The Company's main products include functional skincare products and medical dressings, and they are produced with recombinant collagen as the key bioactive ingredient. The Company also develops and manufactures rare ginsenosides technology-based functional foods. The Company mainly conducts its businesses within the domestic market.
Employees
1,758
More about the company
Date Price Change Volume
25-06-20 51.25 $ +1.99% 12,421,300
25-06-19 50.25 $ -4.01% 12,116,240
25-06-18 52.35 $ -2.88% 17,274,000
25-06-17 53.90 $ -7.07% 24,390,000
25-06-16 58.00 $ -2.44% 12,410,170

Delayed Quote Hong Kong S.E., June 20, 2025 at 04:08 am

More quotes
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
51.25HKD
Average target price
85.35HKD
Spread / Average Target
+66.53%
Consensus

Quarterly revenue - Rate of surprise